Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotics BB536 and LA1 in Colorectal Cancer Surgery
NCT00936572Phase 2Completed
- Sponsor
- University of Milano-Bicocca
- Start
- Oct 2006
- Primary completion
- Jun 2007
- Modality
- Yeast Strains, Defined Consortia, Bacterial Strains
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Bifidobacterium longum BB536 and lactobacillus acidophilus in colorectal cancer (CRC), sponsored by University of Milano-Bicocca. Started Oct 2006; status: completed.
02
Drugs
Bifidobacterium longum BB536lactobacillus acidophilus
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00936572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00936572.